DOCU vs LEXXW · P/E 15, rev $1.71B vs rev $705.9K
DocuSign Inc (DOCU) versus Lexaria Bioscience Corp (LEXXW) — a side-by-side from cached financials, not a winner call.
DocuSign Inc (DOCU) is a software - application company listed on US.
Lexaria Bioscience Corp (LEXXW) common stock listed on US.
Latest reported DOCU revenue for 2026-07-31 was $1.71B. Net income was $155.9M. DOCU currently screens at market cap $15.74B and trailing P/E 14.8.
Latest reported LEXXW revenue for 2025-08-31 was $705.9K. Net income was -$11.9M. Revenue was up 52.0% from 2024-08-31 to 2025-08-31. LEXXW currently screens at market cap $33.8M.
DOCU currently screens at market cap $15.74B and trailing P/E 14.8. LEXXW currently screens at market cap $33.8M.
Not investment advice. Open the DOCU and LEXXW stock pages for the full models.
Not investment advice.